X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (689) 689
certolizumab pegol (648) 648
index medicus (540) 540
infliximab (380) 380
tumor necrosis factor-alpha - antagonists & inhibitors (348) 348
adalimumab (343) 343
antibodies, monoclonal - therapeutic use (275) 275
female (274) 274
crohn's disease (257) 257
gastroenterology & hepatology (255) 255
crohn disease - drug therapy (253) 253
polyethylene glycols - therapeutic use (252) 252
treatment outcome (250) 250
immunoglobulin fab fragments - therapeutic use (240) 240
male (236) 236
adult (221) 221
middle aged (194) 194
inflammatory-bowel-disease (191) 191
antibodies, monoclonal, humanized - therapeutic use (186) 186
double-blind (178) 178
antirheumatic agents - therapeutic use (177) 177
arthritis, rheumatoid - drug therapy (160) 160
maintenance therapy (154) 154
antibodies, monoclonal, humanized (152) 152
rheumatoid arthritis (151) 151
rheumatology (147) 147
immunosuppressive agents - therapeutic use (145) 145
pharmacology & pharmacy (136) 136
crohns-disease (135) 135
certolizumab pegol - therapeutic use (132) 132
anti-inflammatory agents - therapeutic use (129) 129
etanercept (127) 127
inflammatory bowel disease (127) 127
inflammatory bowel diseases - drug therapy (118) 118
rheumatoid-arthritis (116) 116
ulcerative colitis (111) 111
therapy (106) 106
placebo-controlled trial (101) 101
ulcerative-colitis (93) 93
aged (91) 91
drug therapy (89) 89
monoclonal-antibody (88) 88
drug therapy, combination (87) 87
tumor necrosis factor (87) 87
remission induction (85) 85
severity of illness index (82) 82
biological products - therapeutic use (77) 77
immunoglobulin fab fragments - adverse effects (77) 77
young adult (77) 77
animals (76) 76
polyethylene glycols - adverse effects (76) 76
anti-tnf (75) 75
efficacy (73) 73
gastrointestinal agents - therapeutic use (73) 73
randomized-trial (73) 73
tumor-necrosis-factor (72) 72
adalimumab - therapeutic use (71) 71
methotrexate (71) 71
antibodies, monoclonal - adverse effects (68) 68
quality-of-life (68) 68
infliximab - therapeutic use (67) 67
methotrexate - therapeutic use (67) 67
necrosis-factor-alpha (67) 67
tumor necrosis factor-alpha - immunology (67) 67
monoclonal antibodies (66) 66
antitumor necrosis factor (65) 65
care and treatment (64) 64
randomized controlled trials as topic (64) 64
remission (62) 62
safety (62) 62
antibodies, monoclonal, humanized - adverse effects (61) 61
double-blind method (61) 61
risk factors (61) 61
arthritis (58) 58
health aspects (57) 57
medicine, general & internal (56) 56
abridged index medicus (55) 55
quality of life (55) 55
antirheumatic agents - adverse effects (54) 54
clinical-response (54) 54
immunology (54) 54
certolizumab (53) 53
colitis, ulcerative - drug therapy (52) 52
immunologic factors - therapeutic use (51) 51
natalizumab (51) 51
immunosuppressive agents - adverse effects (50) 50
psoriasis (50) 50
biologics (49) 49
clinical trials (49) 49
tumor necrosis factor-tnf (49) 49
adolescent (48) 48
analysis (48) 48
crohn disease - immunology (47) 47
factor-alpha (47) 47
retrospective studies (47) 47
phase-iii (46) 46
arthritis, psoriatic - drug therapy (45) 45
pregnancy (45) 45
medicine & public health (44) 44
golimumab (43) 43
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (778) 778
German (12) 12
Spanish (9) 9
French (7) 7
Japanese (5) 5
Russian (3) 3
Hungarian (2) 2
Danish (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 2017, Volume 56, Issue 9, pp. 1498 - 1509
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 01/2016, Volume 75, Issue 1, pp. 75 - 83
Journal Article
Journal Article
Journal Article